{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:24:49Z","timestamp":1789680289781,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nanostructured lipid carriers (NLCs) have attracted considerable interest as drug delivery systems capable of enhancing the solubility and oral bioavailability of poorly water-soluble drugs. In our previous work, cannabidiol (CBD)-loaded NLCs prepared by hot homogenization demonstrated improved dissolution and oral bioavailability. In the present study, hot-melt extrusion (HME) was investigated as a rapid and easily scalable alternative method for the preparation of CBD NLCs. Additionally, spray drying was used to convert the prepared CBD NLCs into a solid dosage form. CBD NLCs were prepared using HME at different screw speeds (100, 200, and 300\u00a0rpm), followed by probe sonication, and characterized for particle size, entrapment efficiency (EE), and drug release. Spray drying was performed with different carriers (D-lactose, Kollidon\u00ae VA 64, maltodextrin 12, and Soluplus\u00ae) to evaluate their compatibility and performance. The results showed that the screw speed has an impact on the properties of the NLCs, while probe sonication further reduced particle size, resulting in enhanced entrapment efficiency, and drug release of all formulations. Although NLC produced at a screw speed of 300\u00a0rpm was the most stable in both 4\u00a0\u00b0C and 25\u00a0\u00b0C. Among the carriers tested for spray drying, maltodextrin achieved nearly complete CBD release, while Soluplus\u00ae led to increased particle size and reduced release. Overall, HME combined with probe sonication proved to be a robust approach for the preparation of CBD NLCs, which were successfully converted into solid powder formulations by spray drying, offering a promising strategy for scalable production of CBD NLCs.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1208\/s12249-025-03277-3","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:20:38Z","timestamp":1762888838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Utilizing Hot-Melt Extrusion and Spray Drying Techniques for Preparation of Liquid and Solid Cannabidiol Nano-Structured Lipid Carriers Formulations"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3646-7441","authenticated-orcid":false,"given":"Iman E.","family":"Taha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0019-2001","authenticated-orcid":false,"given":"Mahmoud A.","family":"ElSohly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6290-8599","authenticated-orcid":false,"given":"Nourhan","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-5128","authenticated-orcid":false,"given":"Mashan","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9013-1327","authenticated-orcid":false,"given":"Eman A.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"3277_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101899","author":"S Chaturvedi","year":"2020","unstructured":"Chaturvedi S, Garg A, Verma A. Nano lipid based carriers for lymphatic voyage of anti-cancer drugs: an insight into the in-vitro, ex-vivo, in-situ and in-vivo study models. J Drug Deliv Sci Technol. 2020. https:\/\/doi.org\/10.1016\/j.jddst.2020.101899.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3277_CR2","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Lu Y, Qi J, Wu W. An update on oral drug delivery via intestinal lymphatic transport. Acta Pharm Sin B. 2021;11:2449\u201368. https:\/\/doi.org\/10.1016\/j.apsb.2020.12.022.","journal-title":"Acta Pharm Sin B"},{"key":"3277_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061593","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15061593.","journal-title":"Pharmaceutics"},{"key":"3277_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","volume":"51","author":"VR Salvi","year":"2019","unstructured":"Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier. J Drug Deliv Sci Technol. 2019;51:255\u201367. https:\/\/doi.org\/10.1016\/j.jddst.2019.02.017.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"3277_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","volume":"29","author":"M Elmowafy","year":"2021","unstructured":"Elmowafy M, Al-Sanea MM. Nanostructured lipid carriers (NLCs) as drug delivery platform: advances in formulation and delivery strategies. Saudi Pharm J. 2021;29(9):999\u20131012. https:\/\/doi.org\/10.1016\/j.jsps.2021.07.015.","journal-title":"Saudi Pharm J"},{"key":"3277_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2022.100064","volume":"8","author":"VH Nguyen","year":"2022","unstructured":"Nguyen VH, Thuy VN, Van TV, Dao AH, Lee BJ. Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration. Open Nano. 2022;8:100064. https:\/\/doi.org\/10.1016\/j.onano.2022.100064.","journal-title":"Open Nano"},{"key":"3277_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.113734","volume":"316","author":"C Houacine","year":"2020","unstructured":"Houacine C, Adams D, Singh KK. Impact of liquid lipid on development and stability of trimyristin nanostructured lipid carriers for oral delivery of resveratrol. J Mol Liq. 2020;316:113734. https:\/\/doi.org\/10.1016\/j.molliq.2020.113734.","journal-title":"J Mol Liq"},{"key":"3277_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.apsusc.2013.10.006","volume":"288","author":"H Fan","year":"2014","unstructured":"Fan H, Liu G, Huang Y, Li Y, Xia Q. Development of a nanostructured lipid carrier formulation for increasing photo-stability and water solubility of phenylethyl resorcinol. Appl Surf Sci. 2014;288:193\u2013200. https:\/\/doi.org\/10.1016\/j.apsusc.2013.10.006.","journal-title":"Appl Surf Sci"},{"key":"3277_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymeth.2021.05.003","volume":"199","author":"E Gomaa","year":"2022","unstructured":"Gomaa E, Fathi HA, Eissa NG, Elsabahy M. Methods for preparation of nanostructured lipid carriers. Methods. 2022;199:3\u20138. https:\/\/doi.org\/10.1016\/j.ymeth.2021.05.003.","journal-title":"Methods"},{"key":"3277_CR10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.xphs.2016.12.015","volume":"106","author":"AM Bhagurkar","year":"2017","unstructured":"Bhagurkar AM, Repka MA, Murthy SN. A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology. J Pharm Sci. 2017;106:1085\u201391. https:\/\/doi.org\/10.1016\/j.xphs.2016.12.015.","journal-title":"J Pharm Sci"},{"key":"3277_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102673","volume":"65","author":"D Muhindo","year":"2021","unstructured":"Muhindo D, Ashour EA, Almutairi M, Joshi PH, Repka MA. Continuous production of raloxifene hydrochloride loaded nanostructured lipid carriers using hot-melt extrusion technology. J Drug Deliv Sci Technol. 2021;65:102673. https:\/\/doi.org\/10.1016\/j.jddst.2021.102673.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3277_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph14010073","volume":"14","author":"BR Giri","year":"2021","unstructured":"Giri BR, Kwon J, Vo AQ, Bhagurkar AM, Bandari S, Kim DW. Hot-melt extruded amorphous solid dispersion for solubility, stability, and bioavailability enhancement of telmisartan. Pharmaceuticals. 2021;14:1\u201318. https:\/\/doi.org\/10.3390\/ph14010073.","journal-title":"Pharmaceuticals"},{"key":"3277_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ejps.2012.12.012","volume":"48","author":"AL Sarode","year":"2013","unstructured":"Sarode AL, Sandhu H, Shah N, Malick W, Zia H. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur J Pharm Sci. 2013;48:371\u201384. https:\/\/doi.org\/10.1016\/j.ejps.2012.12.012.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"3277_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5281\/zenodo.10950451","volume":"2","author":"P Saranya","year":"2024","unstructured":"Saranya P, Mahapatra S, Rakshana V, Srinivasan R. Advancements and Challenges in Hot Melt Extrusion (HME) for Pharmaceutical Applications. Journal of Pharma Insights and Research. 2024;2(2):110\u20134. https:\/\/doi.org\/10.5281\/zenodo.10950451.","journal-title":"Journal of Pharma Insights and Research"},{"key":"3277_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051044","author":"SO Kyeremateng","year":"2022","unstructured":"Kyeremateng SO, Voges K, Dohrn S, Sobich E, Lander U, Weber S, et al. A hot-melt extrusion risk assessment classification system for amorphous solid dispersion formulation development. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14051044.","journal-title":"Pharmaceutics"},{"key":"3277_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ijpharm.2019.05.029","volume":"566","author":"GP Andrews","year":"2019","unstructured":"Andrews GP, Jones DS, Senta-Loys Z, Almajaan A, Li S, Chevallier O, et al. The development of an inline Raman spectroscopic analysis method as a quality control tool for hot melt extruded ramipril fixed-dose combination products. Int J Pharm. 2019;566:476\u201387. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.05.029.","journal-title":"Int J Pharm"},{"key":"3277_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030089","author":"R Censi","year":"2018","unstructured":"Censi R, Gigliobianco MR, Casadidio C, Di Martino P. Hot melt extrusion: highlighting physicochemical factors to be investigated while designing and optimizing a hot melt extrusion process. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10030089.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3277_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","volume":"25","author":"R Vehring","year":"2008","unstructured":"Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res. 2008;25(5):999\u20131022. https:\/\/doi.org\/10.1007\/s11095-007-9475-1.","journal-title":"Pharm Res"},{"key":"3277_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.foodres.2007.07.004","volume":"40","author":"A Gharsallaoui","year":"2007","unstructured":"Gharsallaoui A, Roudaut G, Chambin O, Voilley A, Saurel R. Applications of spray-drying in microencapsulation of food ingredients: an overview. Food Res Int. 2007;40:1107\u201321. https:\/\/doi.org\/10.1016\/j.foodres.2007.07.004.","journal-title":"Food Res Int"},{"key":"3277_CR20","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/jps","volume":"101","author":"D Psimadas","year":"2012","unstructured":"Psimadas D, Georgoulias P, Valotassiou V, Loudos G. Molecular Nanomedicine Towards Cancer\u202f: J Pharm Sci. 2012;101:2271\u201380. https:\/\/doi.org\/10.1002\/jps.","journal-title":"Molecular Nanomedicine Towards Cancer : J Pharm Sci"},{"key":"3277_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jfoodeng.2014.09.004","volume":"146","author":"S Keshani","year":"2015","unstructured":"Keshani S, Daud WRW, Nourouzi MM, Namvar F, Ghasemi M. Spray drying: an overview on wall deposition, process and modeling. J Food Eng. 2015;146:152\u201362. https:\/\/doi.org\/10.1016\/j.jfoodeng.2014.09.004.","journal-title":"J Food Eng"},{"issue":"1","key":"3277_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010122","volume":"17","author":"S Dattani","year":"2025","unstructured":"Dattani S, Li X, Lampa C, Barriscale A, Damadzadeh B, Lechuga-Ballesteros D, et al. Development of spray-dried micelles, liposomes, and solid lipid nanoparticles for enhanced stability. Pharmaceutics. 2025;17(1):122. https:\/\/doi.org\/10.3390\/pharmaceutics17010122.","journal-title":"Pharmaceutics"},{"key":"3277_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.afres.2025.100721","author":"L Sapei","year":"2025","unstructured":"Sapei L, Mustika PCBW, Sutrisna PD, Agustriyanto R, Setyopratomo P, Santoso GV, et al. Inulin-coated virgin coconut oil (VCO) powder produced by spray drying. Applied Food Research. 2025. https:\/\/doi.org\/10.1016\/j.afres.2025.100721.","journal-title":"Applied Food Research"},{"key":"3277_CR24","unstructured":"Buckner CA, Lafrenie RM, D\u00e9nomm\u00e9e JA, Caswell JM, Want DA, Gan GG, et al. Spray Drying: An Overview. 2016;11:13. https:\/\/www.intechopen.com\/books\/advanced-biometric-technologies\/liveness-detection-in-biometrics"},{"key":"3277_CR25","unstructured":"S, Jian Manu, B, Lohare Ganesh, M, Bari Manoji, B, Chavan Randhir D, Barhate Shashikant B SC. Spray Drying in Pharmaceutical Industry\u202f: A Review Spray Drying in Pharmaceutical Industry\u202f: A Review. 2016;4:0\u20136."},{"key":"3277_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/03602550600685275","volume":"24","author":"M Ameri","year":"2006","unstructured":"Ameri M, Maa YF. Spray drying of biopharmaceuticals: stability and process considerations. Drying Technol. 2006;24:763\u20138. https:\/\/doi.org\/10.1080\/03602550600685275.","journal-title":"Drying Technol"},{"key":"3277_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pr8070788","author":"M Malamatari","year":"2020","unstructured":"Malamatari M, Charisi A, Malamataris S, Kachrimanis K, Nikolakakis I. Spray drying for the preparation of nanoparticle-based drug formulations as dry powders for inhalation. Processes. 2020. https:\/\/doi.org\/10.3390\/pr8070788.","journal-title":"Processes"},{"key":"3277_CR28","doi-asserted-by":"publisher","DOI":"10.5897\/ajfs2015.1279","author":"SC Samantha","year":"2015","unstructured":"Samantha SC, Bruna ASM, Adriana RM, Fabio B, Sandro AR, Aline RCA. Drying by spray drying in the food industry: micro-encapsulation, process parameters and main carriers used. Afr J Food Sci. 2015. https:\/\/doi.org\/10.5897\/ajfs2015.1279.","journal-title":"Afr J Food Sci"},{"key":"3277_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/foods10091968","author":"K \u0160avikin","year":"2021","unstructured":"\u0160avikin K, Nasti\u0107 N, Jankovi\u0107 T, Bigovi\u0107 D, Mili\u010devi\u0107 B, Vidovi\u0107 S. Effect of type and concentration of carrier material on the encapsulation of pomegranate peel using spray drying method. Foods. 2021. https:\/\/doi.org\/10.3390\/foods10091968.","journal-title":"Foods"},{"key":"3277_CR30","doi-asserted-by":"publisher","unstructured":"Ziaee A, Albadarin AB, Padrela L, Femmer T, O\u2019Reilly E, Walker G. Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches. Eur J Pharm Sci. 2019; 300\u2013318. https:\/\/doi.org\/10.1016\/j.ejps.2018.10.026.","DOI":"10.1016\/j.ejps.2018.10.026"},{"key":"3277_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/07373937.2012.666608","author":"DF Cort\u00e9s-Rojas","year":"2012","unstructured":"Cort\u00e9s-Rojas DF, Oliveira WP. Physicochemical properties of phytopharmaceutical preparations as affected by drying methods and carriers. Drying Technol. 2012. https:\/\/doi.org\/10.1080\/07373937.2012.666608.","journal-title":"Drying Technol"},{"key":"3277_CR32","doi-asserted-by":"publisher","DOI":"10.1159\/000540353","author":"IE Taha","year":"2024","unstructured":"Taha IE, ElSohly MA, Radwan MM, Omari S, Ashour EA. Development and in vitro evaluation of cannabidiol mucoadhesive buccal film formulations using hot-melt extrusion technology. Med Cannabis Cannabinoids. 2024. https:\/\/doi.org\/10.1159\/000540353.","journal-title":"Med Cannabis Cannabinoids"},{"key":"3277_CR33","doi-asserted-by":"publisher","unstructured":"Cassano T, Villani R, Pace L, Carbone A, Bukke VN, Orkisz S, et al. From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases. Front Pharmacol. 2020; 1\u201310. https:\/\/doi.org\/10.3389\/fphar.2020.00124.","DOI":"10.3389\/fphar.2020.00124"},{"issue":"10","key":"3277_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23102478","volume":"23","author":"N Bruni","year":"2018","unstructured":"Bruni N, Pepa C Della, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F, et al. Cannabinoid delivery systems for pain and inflammation treatment. Molecules. 2018;2478. https:\/\/doi.org\/10.3390\/molecules23102478.","journal-title":"Molecules"},{"key":"3277_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2023.103828","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Du Z, Qu K, Shen Y, Jiang Y, Zhu H, et al. Adverse events of epidiolex: a real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database. Asian J Psychiatr. 2023. https:\/\/doi.org\/10.1016\/j.ajp.2023.103828.","journal-title":"Asian J Psychiatr"},{"key":"3277_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113203","author":"ES Seltzer","year":"2020","unstructured":"Seltzer ES, Watters AK, Mackenzie D, Granat LM, Zhang D. Cannabidiol (Cbd) as a promising anti-cancer drug. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12113203.","journal-title":"Cancers"},{"key":"3277_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgab011","author":"M Sexton","year":"2021","unstructured":"Sexton M, Garcia JM, Jatoi A, Clark CS, Wallace MS. The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids. JNCI Monogr. 2021. https:\/\/doi.org\/10.1093\/jncimonographs\/lgab011.","journal-title":"JNCI Monogr"},{"key":"3277_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063344","author":"C Pagano","year":"2022","unstructured":"Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Cannabinoids: therapeutic use in clinical practice. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23063344.","journal-title":"Int J Mol Sci"},{"key":"3277_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00741-5","author":"E Perucca","year":"2020","unstructured":"Perucca E, Bialer M. Critical aspects affecting cannabidiol oral bioavailability and metabolic elimination, and related clinical implications. CNS Drugs. 2020. https:\/\/doi.org\/10.1007\/s40263-020-00741-5.","journal-title":"CNS Drugs"},{"key":"3277_CR40","doi-asserted-by":"publisher","DOI":"10.1159\/000534473","author":"MA Elsohly","year":"2023","unstructured":"Elsohly MA, Shahzadi I, Gul W. Absorption and bioavailability of novel UltraShear nanoemulsion of cannabidiol in rats. Med Cannabis Cannabinoids. 2023. https:\/\/doi.org\/10.1159\/000534473.","journal-title":"Med Cannabis Cannabinoids"},{"issue":"8","key":"3277_CR41","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s13346-024-01766-9","volume":"15","author":"IE Taha","year":"2025","unstructured":"Taha IE, ElSohly MA, Radwan MM, Elkanayati RM, Wanas A, Joshi PH, et al. Enhancement of cannabidiol oral bioavailability through the development of nanostructured lipid carriers: in vitro and in vivo evaluation studies. Drug Deliv Transl Res. 2025;15(8):2722\u201332. https:\/\/doi.org\/10.1007\/s13346-024-01766-9.","journal-title":"Drug Deliv Transl Res"},{"key":"3277_CR42","doi-asserted-by":"publisher","DOI":"10.5740\/jaoacint.15-095","author":"W Gul","year":"2015","unstructured":"Gul W, Gul SW, Radwan MM, Wanas AS, Mehmedic Z, Khan II, et al. Determination of 11 cannabinoids in biomass and extracts of different varieties of cannabis using high-performance liquid chromatography. J AOAC Int. 2015. https:\/\/doi.org\/10.5740\/jaoacint.15-095.","journal-title":"J AOAC Int"},{"key":"3277_CR43","doi-asserted-by":"publisher","unstructured":"Shen J, Burgess DJ. In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug delivery and translational research. 2013 Oct; 3:409\u20134015. https:\/\/https:\/\/doi.org\/10.1007\/s13346-013-0129-z.","DOI":"10.1007\/s13346-013-0129-z"},{"key":"3277_CR44","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c14-00030","author":"ES Ha","year":"2014","unstructured":"Ha ES, Baek IH, Cho W, Hwang SJ, Kim MS. Preparation and evaluation of solid dispersion of atorvastatin calcium with soluplus\u00ae by spray drying technique. Chem Pharm Bull. 2014. https:\/\/doi.org\/10.1248\/cpb.c14-00030.","journal-title":"Chem Pharm Bull"},{"key":"3277_CR45","doi-asserted-by":"publisher","DOI":"10.22037\/ijpr.2015.1621","author":"A Homayouni","year":"2015","unstructured":"Homayouni A, Sadeghi F, Nokhodchi A, Varshosaz J, Garekani HA. Preparation and characterization of celecoxib dispersions in soluplus\u00ae: comparison of spray drying and conventional methods. Iran J Pharm Res. 2015. https:\/\/doi.org\/10.22037\/ijpr.2015.1621.","journal-title":"Iran J Pharm Res"},{"key":"3277_CR46","doi-asserted-by":"publisher","unstructured":"Ziaee A, Albadarin AB, Padrela L, Faucher A, O\u2019Reilly E, Walker G. Spray drying ternary amorphous solid dispersions of ibuprofen \u2013 An investigation into critical formulation and processing parameters. Eur J Pharm Biopharm. 2017; 43\u201351. https:\/\/doi.org\/10.1016\/j.ejpb.2017.08.005.","DOI":"10.1016\/j.ejpb.2017.08.005"},{"key":"3277_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2058651","author":"Y Agrawal","year":"2022","unstructured":"Agrawal Y, Patil K, Mahajan H, Potdar M, Joshi P, Nakhate K. In vitro and in\u00a0vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach. Drug Deliv. 2022. https:\/\/doi.org\/10.1080\/10717544.2022.2058651.","journal-title":"Drug Deliv"},{"key":"3277_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10020057","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10020057.","journal-title":"Pharmaceutics"},{"key":"3277_CR49","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S274352","author":"RH Awadeen","year":"2020","unstructured":"Awadeen RH, Boughdady MF, Meshali MM. Quality by design approach for preparation of Zolmitriptan\/Chitosan nanostructured lipid carrier particles \u2013 formulation and pharmacodynamic assessment. Int J Nanomedicine. 2020. https:\/\/doi.org\/10.2147\/IJN.S274352.","journal-title":"Int J Nanomedicine"},{"key":"3277_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s44174-022-00041-0","author":"R Kesharwani","year":"2023","unstructured":"Kesharwani R, Jaiswal P, Patel DK, Yadav PK. Lipid-based drug delivery system (LBDDS): an emerging paradigm to enhance oral bioavailability of poorly soluble drugs. Biomedical Materials & Devices. 2023. https:\/\/doi.org\/10.1007\/s44174-022-00041-0.","journal-title":"Biomedical Materials & Devices"},{"issue":"1\u20132","key":"3277_CR51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijpharm.2014.05.024","volume":"471","author":"H Patil","year":"2014","unstructured":"Patil H, Kulkarni V, Majumdar S, Repka MA. Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion. Int J Pharm. 2014;471(1\u20132):153\u20136. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.05.024.","journal-title":"Int J Pharm"},{"key":"3277_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-024-09859-1","author":"V Sabale","year":"2024","unstructured":"Sabale V, Nikam M, Sabale P. Formulation, optimization and in vitro studies of flutamide-loaded nanostructured lipid carrier based oral drug delivery for enhanced anticancer activity. J Pharm Innov. 2024. https:\/\/doi.org\/10.1007\/s12247-024-09859-1.","journal-title":"J Pharm Innov"},{"key":"3277_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102352","author":"S Dolatabadi","year":"2021","unstructured":"Dolatabadi S, Karimi M, Nasirizadeh S, Hatamipour M, Golmohammadzadeh S, Jaafari MR. Preparation, characterization and in vivo pharmacokinetic evaluation of curcuminoids-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs). J Drug Deliv Sci Technol. 2021. https:\/\/doi.org\/10.1016\/j.jddst.2021.102352.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3277_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102470","author":"S Scioli Montoto","year":"2021","unstructured":"Scioli Montoto S, Muraca G, Di Ianni M, Couyoupetrou M, Pesce G, Islan GA, et al. Preparation, physicochemical and biopharmaceutical characterization of oxcarbazepine-loaded nanostructured lipid carriers as potential antiepileptic devices. J Drug Deliv Sci Technol. 2021. https:\/\/doi.org\/10.1016\/j.jddst.2021.102470.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3277_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040437","author":"P Mura","year":"2021","unstructured":"Mura P, Maestrelli F, D\u2019Ambrosio M, Luceri C, Cirri M. Evaluation and comparison of solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as vectors to develop hydrochlorothiazide effective and safe pediatric oral liquid formulations. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13040437.","journal-title":"Pharmaceutics"},{"key":"3277_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.120113","author":"Z Xiao","year":"2022","unstructured":"Xiao Z, Xia J, Zhao Q, Niu Y, Zhao D. Maltodextrin as wall material for microcapsules: a review. Carbohydr Polym. 2022. https:\/\/doi.org\/10.1016\/j.carbpol.2022.120113.","journal-title":"Carbohydr Polym"},{"issue":"9","key":"3277_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17091163","volume":"17","author":"A Karimi","year":"2025","unstructured":"Karimi A, Barea P, Benito-Rom\u00e1n \u00d3, Blanco B, Sanz MT, Higginbotham CL, et al. Investigation of fenbendazole solubility using particle size reduction methods in the presence of Soluplus\u00ae. Pharmaceutics. 2025;17(9):1163. https:\/\/doi.org\/10.3390\/pharmaceutics17091163.","journal-title":"Pharmaceutics"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03277-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:05:40Z","timestamp":1770314740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03277-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3277"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03277-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"26"}}